Therapeutic BCL11A enhancer gene editing to induce fetal hemoglobin in β-hemoglobinopathy patients

NIH RePORTER · NIH · OT2 · $886,788 · view on reporter.nih.gov ↗

Abstract

No abstract provided

Key facts

NIH application ID
10317505
Project number
3OT2HL154984-01S1
Recipient
BOSTON CHILDREN'S HOSPITAL
Principal Investigator
Daniel Evan Bauer
Activity code
OT2
Funding institute
NIH
Fiscal year
2021
Award amount
$886,788
Award type
3
Project period
2020-06-18 → 2022-11-30